ADVFN ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Cytek Biosciences Inc

Cytek Biosciences Inc (CTKB)

4.62
0.03
(0.65%)
Cerrado 10 Julio 3:00PM
4.62
-0.01
(-0.22%)
Fuera de horario: 3:03PM

Cytek Biosciences Inc (CTKB) Cotización

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Premium

Estadísticas y detalles clave

Último Precio
4.62
( 0.65% )
Postura de Compra
4.50
Postura de Venta
4.81
Volume Operado de la Acción
788,325
Volumen promedio (3 m)
US$ 1,326,197
Volumen financiero
US$ 3,624,141
4.525 Rango del Día 4.68
3.09 Rango de 52 semanas 6.18
Capitalización de Mercado [m]
Valor de Empresa
358.021M
Precio Anterior
4.59
Precio de Apertura
4.58
Última hora de negociación
Precio Promedio Ponderado
4.5973
turnover
204.17M
Beneficio neto
-74M
Acciones en circulación
129,142,587
Flotante (%)
74.79%
Propiedad Institucional (%)
67.34%
Rendimiento del Dividendo (LTM)
Ratio Precio/Utilidad
-7.91
Precio/Ventas (P/V)
2.9
Beneficio por acción (BPA)
-0.58
Beta
1.17

Acerca de Cytek Biosciences Inc

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitate scientific advances in biomedical research and clinical applications. The company offers Cytek aurora, northern lights systems, and Cytek aurora evo systems delivers cell analysis; Cytek Aurora C... Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitate scientific advances in biomedical research and clinical applications. The company offers Cytek aurora, northern lights systems, and Cytek aurora evo systems delivers cell analysis; Cytek Aurora CS System, a cellular complexity to perform additional downstream genomic and proteomic studies using phenotyping approaches; enhanced small particle detection; Cytek amnis imagestream imaging flow cytometers; Cytek guava muse cell analyzers; Cytek muse micro cell analyzers; Cytek guava easyCyte flow cytometers; and Cytek orion reagent cocktail preparation systems. It also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments. In addition, the company offers automated micro-sampling system and automated sample loader system, an automated loaders designed to integrate seamlessly into the Cytek aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for Cytek aurora, northern lights, and Cytek aurora evo systems; and customer support tools. Further, it provides conventional flow and image-based flow cytometry instrumentation and related products and services under the Amnis and Guava brand names. The company serves pharmaceutical and biopharma companies, academic research centers, and contract research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in Europe, Latin America, and the Middle East countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California. Mostrar más

Sector
Health Care
Industria
-
Sitio web
Sede
Fremont, United States
Fundado
1992
Cytek Biosciences Inc is listed in the Health Care sector of the NASDAQ with ticker CTKB. The last closing price for Cytek Biosciences was US$4.59. Over the last year, Cytek Biosciences shares have traded in a share price range of US$ 3.09 to US$ 6.18.

Cytek Biosciences currently has 129,142,587 shares in issue. The market capitalisation of Cytek Biosciences is US$596.64 million. Cytek Biosciences has a price to earnings ratio (PE ratio) of -7.91.

CTKB Últimas noticias

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10.061.315789473684.564.7354.319524984.5296524CS
40.5613.79310344834.064.7353.724152754.05557333CS
12-0.09-1.910828025484.714.993.3114323024.07474622CS
26-1.03-18.23008849565.655.993.3110602394.29628212CS
521.0830.50847457633.546.183.0910685184.36875616CS
156-3.83-45.3254437878.459.872.379098755.23951141CS
260-15.48-77.014925373120.128.72.378420117.68729087CS

CTKB - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Cytek Biosciences Inc?
El precio actual de las acciones de Cytek Biosciences Inc es US$ 4.62
¿Cuántas acciones de Cytek Biosciences Inc están en circulación?
Cytek Biosciences Inc tiene 129,142,587 acciones en circulación
¿Cuál es la capitalización de mercado de Cytek Biosciences Inc?
La capitalización de mercado de Cytek Biosciences Inc es USD 596.64M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Cytek Biosciences Inc?
Cytek Biosciences Inc ha negociado en un rango de US$ 3.09 a US$ 6.18 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Cytek Biosciences Inc?
El ratio precio/beneficio de Cytek Biosciences Inc es -7.91
¿Cuál es el ratio de efectivo a ventas de Cytek Biosciences Inc?
El ratio de efectivo a ventas de Cytek Biosciences Inc es 2.9
¿Cuál es la dirección registrada de Cytek Biosciences Inc?
La dirección registrada de Cytek Biosciences Inc es 47215 Lakeview Blvd, Fremont, California, 94538-6407
¿Cuál es la dirección del sitio web de Cytek Biosciences Inc?
La dirección del sitio web de Cytek Biosciences Inc es cytekbio.com

CTKB Operaciones

Más

Operaciones con retraso

Para obtener operaciones en tiempo real, actualice su cuenta

Actualizar a tiempo real
bodyshop13 bodyshop13 6 minutos hace
Will you pound your cousin? You live in the proper state.
IFUS
ron_66271 ron_66271 6 minutos hace
Gemini Just Doesn’t Understand That WMB Never Failed.

We know that WMB was used to shore-up JPM because JPM ran out of money trying to cover their underwater derivatives.

From JPM’s 2008 10K;
JPM TIER 1 was 3.5.
WMB TIER 1 was 7.8.

And don’t
RKT
Shrinky Dynk Shrinky Dynk 7 minutos hace
yeah probably @ .0001
SGMD
Gold prospector Gold prospector 8 minutos hace
Post a link I just looked. It’s not the same guy.
CCLX
mike_dotcom mike_dotcom 10 minutos hace
Six million shares have been covered without moving the stock UP one penny.
AVXL
4retire 4retire 10 minutos hace
You bet I am. Haven’t sold a share. Was so darn lucky years ago when I bought a bunch at a very low price. NVDA has made a lot of people very happy. Others, not so much
NVDA
bullmkt99 bullmkt99 11 minutos hace
https://x.com/javilealoficial/status/2075720723524431878?s=20

"Great close to a productive week.

The next 1–2 weeks will be important for the Company. A lot of work is happening, and we’re making meaningful progress on several initiatives.

Nothing is offi
SNTX
goodietime goodietime 12 minutos hace
Not sure WHAT you are trying to convey??

SURE LOOKS FINE TO ME.

Friday, July 10, 2026

https://patriot.tv/
CBMJ
hedge_fun hedge_fun 12 minutos hace
This was posted last year. I’ll share……

more, but the file is quite large.

Snipping every page is not my intent. If you need more info make your own Freedom of Information Request as I did.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=
SFRX
gutedogg gutedogg 12 minutos hace
AWESOME DD JAB...youve been amazing on that for years...G
TGLO
Goats'nCrows Goats'nCrows 13 minutos hace
I think we just got the leverage we needed to pressure favorable settlements, so while some may want to see him give testimony in some format, imo, that is unlikely.

Very soon, I believe we will walk off to a profitable future, and he will continue his writing with a reputation furt
NWBO
Longstrongsilver Longstrongsilver 13 minutos hace
lol no one’s buying your bruised knees fake yawn. No amount of your false bravado will help you here. You’re also wrong about the number one sogn of a scam. It is t dilution. That can be a bad sign but most dillution is legit. Having a lying fake ceo who pumps his stick while sticking shareholder
AZRH
JerryCampbell JerryCampbell 14 minutos hace
As a journalist AF would get strong legal protection against revealing confidential sources. Probably pointless to call him as a witness.

Opinion rather than legal analysis...
NWBO
SSKILLZ1 SSKILLZ1 14 minutos hace
Pick 4 Contest #24 Contest Week 8 Results In

Hope everyone enjoys the stats and has fun in the contest. Hope this helps.

https://investorshub.advfn.com/Pick-4-Contest-No-24-50633
SSKILLZ1 SSKILLZ1 14 minutos hace
Pick 4 Contest #24 Contest Week 8 Results In

Hope everyone enjoys the stats and has fun in the contest. Hope this helps.

https://investorshub.advfn.com/Pick-4-Contest-No-24-50633
King-of-Huns King-of-Huns 15 minutos hace
Yes i know. I can understand the frustration. I am in same situation as you are. But don’t have any other options, except to wait and see
PDIV
Idunno Idunno 16 minutos hace
Civil trial, at this juncture, btw. 
NWBO
CatfishHunter CatfishHunter 16 minutos hace
The IDE approval isn’t “fluff” — it’s FDA clearance to start first-in-human trials at Mayo Clinic for a Breakthrough Device. That’s a real regulatory milestone after addressing prior feedback, incorporating IsoPet safety data (200+ cases, strong profile) and India human results.

Yes,
RDGL
Idunno Idunno 17 minutos hace
I am not threatening anyone…  Answer the question? Do you think he will be the subject of a Deposition Subpoena, as a witness, right, if/when this goes to trial? As a witness. What do you think? Perhaps Brazen can opine. ? 
NWBO
SSKILLZ1 SSKILLZ1 17 minutos hace
Pick 4 Contest #24 Standings (Week 8)

Congrats to our current leader VALUEMIND up 31.30% so far in the contest. There are 17/31 portfolio up in the contest or 54.84%. So without any further ado the info. is below.
[pre]
Alias % Gain/Loss
J0L J0L 18 minutos hace
It’s legit.  Check CEO’s LinkedIn page, he was appointed CEO of CableClix 2 months ago to lead the company’s relaunch and growth strategy.  I’ve spent the past few hours going through the DD here and it’s some of the best you will ever find.  Hopefully you didn’t sell today, it’s going to be a chase
CCLX
urge2surge urge2surge 18 minutos hace
Anyone contact the transfer agent? Most likely blacked out by the company. Authorized is 100 million so without a filing or vote they can't exceed. Really low for the otc regardless of the dilution imo.
GNIS
infamous infamous 18 minutos hace
Cash secured puts
SOFI
zakattack zakattack 19 minutos hace
Another week of nothing funny the deal was done and was any minute to filed 2 week later smfh these clowns just lie without any standards
PDIV
SSKILLZ1 SSKILLZ1 19 minutos hace
The Picks For Pick 4 Contest #24 (Revised)

Commentary: This basically shows what everyone has now in the contest. The bolded Picks are things that were changed since the start of the contest.
[pre]
Alias SP #1 SP #2 SP &#x
ABVX ACHR ADBE

Su Consulta Reciente